[ad_1] BOSTON and MONTREAL, Sept. 7, 2023 /PRNewswire/ – enGene, Inc., a clinical-stage biotechnology company mainstreaming gene therapy through its novel platform for the delivery of therapeutics to mucosal tissues…
[ad_1] BOSTON and MONTREAL, Sept. 7, 2023 /PRNewswire/ – enGene, Inc., a clinical-stage biotechnology company mainstreaming gene therapy through its novel platform for the delivery of therapeutics to mucosal tissues…